Literature DB >> 31595059

Palindromic rheumatism as part of the rheumatoid arthritis continuum.

Kulveer Mankia1,2, Paul Emery3,4.   

Abstract

Palindromic rheumatism is a distinctive syndrome that has a long-recognized association with rheumatoid arthritis (RA). Palindromic rheumatism is characterized by intermittent flares of pain, erythema and swelling in and around the joints, which are typically severe and unpredictable. The observation that most patients with palindromic rheumatism have RA-related autoantibodies and that many eventually develop RA has led to palindromic rheumatism often being viewed as a relapsing-remitting variant of RA. However, the clinical and imaging phenotypes of palindromic rheumatism suggest important distinctions from RA and imply underlying mechanistic differences between the two conditions. Furthermore, the pattern of inflammation seen in palindromic rheumatism has interesting parallels with that seen in other groups of symptomatic individuals at risk of developing RA. In this Review, we explore the concept of palindromic rheumatism as part of the RA continuum and propose an updated disease paradigm for this unique syndrome.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31595059     DOI: 10.1038/s41584-019-0308-5

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  59 in total

1.  The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis.

Authors:  Anthony S Russell; Al Devani; Walter P Maksymowych
Journal:  J Rheumatol       Date:  2006-05-15       Impact factor: 4.666

2.  Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism.

Authors:  M Tamai; A Kawakami; N Iwamoto; K Arima; K Aoyagi; K Eguchi
Journal:  Scand J Rheumatol       Date:  2010-08       Impact factor: 3.641

3.  Palindromic rheumatism.

Authors:  S Mattingly
Journal:  Ann Rheum Dis       Date:  1966-07       Impact factor: 19.103

4.  Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.

Authors:  L Gonzalez-Lopez; J I Gamez-Nava; G S Jhangri; C Ramos-Remus; A S Russell; M E Suarez-Almazor
Journal:  J Rheumatol       Date:  1999-03       Impact factor: 4.666

Review 5.  What can palindromic rheumatism tell us?

Authors:  Kulveer Mankia; Paul Emery
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-10-25       Impact factor: 4.098

6.  Palindromic rheumatism: longterm outcomes of 60 patients diagnosed in 1967-84.

Authors:  Essi Koskinen; Pekka Hannonen; Tuulikki Sokka
Journal:  J Rheumatol       Date:  2009-07-31       Impact factor: 4.666

7.  Palindromic rheumatism. A clinical survey of sixty patients.

Authors:  P Hannonen; T Möttönen; M Oka
Journal:  Scand J Rheumatol       Date:  1987       Impact factor: 3.641

Review 8.  Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis.

Authors:  P A Guerne; M H Weisman
Journal:  Am J Med       Date:  1992-10       Impact factor: 4.965

9.  Palindromic rheumatism. Clinical and serum complement study.

Authors:  M A Wajed; D L Brown; H L Currey
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

10.  In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up.

Authors:  Yasser Emad; Ashraf Anbar; Ihab Abo-Elyoun; Nashwa El-Shaarawy; Hadeel Al-Hanafi; Hatem Darwish; Mona Gamil; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2014-03-13       Impact factor: 2.980

View more
  7 in total

1.  T-cell responses to hybrid insulin peptides prior to type 1 diabetes development.

Authors:  Angela M Mitchell; Aimon A Alkanani; Kristen A McDaniel; Laura Pyle; Kathleen Waugh; Andrea K Steck; Maki Nakayama; Liping Yu; Peter A Gottlieb; Marian J Rewers; Aaron W Michels
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

Review 2.  Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis.

Authors:  Maya H Buch; Stephen Eyre; Dennis McGonagle
Journal:  Nat Rev Rheumatol       Date:  2020-12-08       Impact factor: 20.543

Review 3.  Pre-RA: Can early diagnosis lead to prevention?

Authors:  Salina Haville; Kevin D Deane
Journal:  Best Pract Res Clin Rheumatol       Date:  2022-01-03       Impact factor: 4.098

4.  Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination.

Authors:  Azam Safary; Kamal Esalatmanesh; Amir Taher Eftekharsadat; Mohammad-Reza Jafari Nakjavani; Alireza Khabbazi
Journal:  Int Immunopharmacol       Date:  2022-07-15       Impact factor: 5.714

5.  Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis.

Authors:  Raul Castellanos-Moreira; Sebastian C Rodriguez-Garcia; Sonia Cabrera-Villalba; María José Gomara; Georgina Salvador; Virginia Ruiz-Esquide; Julio Ramirez; Jose Inciarte-Mundo; Rosa Morla; Cristina Garcia-Moreno; Andrea Cuervo; Jose A Gómez-Puerta; Juan D Cañete; Isabel Haro; Raimon Sanmarti
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-10       Impact factor: 5.346

6.  Palindromic Rheumatism: Just a Pre-rheumatoid Stage or Something Else?

Authors:  Raimon Sanmartí; Beatriz Frade-Sosa; Rosa Morlà; Raul Castellanos-Moreira; Sonia Cabrera-Villalba; Julio Ramirez; Georgina Salvador; Isabel Haro; Juan D Cañete
Journal:  Front Med (Lausanne)       Date:  2021-03-25

Review 7.  The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on "At-Risk" Individuals.

Authors:  Laurence Duquenne; Rahaymin Chowdhury; Kulveer Mankia; Paul Emery
Journal:  Front Med (Lausanne)       Date:  2020-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.